CLINICAL NUTRITION, cilt.33, sa.5, ss.815-822, 2014 (SCI-Expanded, Scopus)
Objective: Given that serum phospholipids (PL) may serve as inflammation mediators, we studied whether they predicted metabolic syndrome (MetS), type-2 diabetes or coronary heart disease (CHD) risk in people prone to enhanced low-grade inflammation.